Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. - Wikidata - wikimedia - TriplyDB

Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses.

Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses.

http://www.wikidata.org/entity/Q36294340

about

The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings Circulating Th17, Th22, and Th1 cells are increased in psoriasis Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab New era of biologic therapeutics in atopic dermatitis Putting together the psoriasis puzzle: an update on developing targeted therapies Novel concept of iSALT (inducible skin-associated lymphoid tissue) in the elicitation of allergic contact dermatitis Psoriasis: new comorbidities Novel insights into the role of immune cells in skin and inducible skin-associated lymphoid tissue (iSALT)IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis Post-therapeutic relapse of psoriasis after CD11a blockade is associated with T cells and inflammatory myeloid DCs Biologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring.Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis.Replication of association between ADAM33 polymorphisms and psoriasis.Vitamin D analogs differentially control antimicrobial peptide/"alarmin" expression in psoriasis.Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production.Evaluation of the psoriasis transcriptome across different studies by gene set enrichment analysis (GSEA).RIG-I antiviral signaling drives interleukin-23 production and psoriasis-like skin disease.Effects of Topical Application of Betamethasone on Imiquimod-induced Psoriasis-like Skin Inflammation in Mice.Myeloid dendritic cells from human cutaneous squamous cell carcinoma are poor stimulators of T-cell proliferation.Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis.Cytokine-producing dendritic cells in the pathogenesis of inflammatory skin diseases.Th17 cells and activated dendritic cells are increased in vitiligo lesions Evidence for altered Wnt signaling in psoriatic skin.Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis.Early tissue responses in psoriasis to the antitumour necrosis factor-α biologic etanercept suggest reduced interleukin-17 receptor expression and signalling.IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells.Human keratinocytes' response to injury upregulates CCL20 and other genes linking innate and adaptive immunity Age-related T-cell cytokine profile parallels corneal disease severity in Sjogren's syndrome-like keratoconjunctivitis sicca in CD25KO mice Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis.Sun exposure induces rapid immunological changes in skin and peripheral blood in patients with psoriasis.Immunologic biomarkers for clinical and therapeutic management of psoriasis.Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasis The role of TNF inhibitors in psoriasis therapy: new implications for associated comorbidities.Redox imbalance in T cell-mediated skin diseases.Biological products for the treatment of psoriasis: therapeutic targets, pharmacodynamics and disease-drug-drug interaction implications A subpopulation of CD163-positive macrophages is classically activated in psoriasis.The pathophysiological role of dendritic cell subsets in psoriasis.Effective narrow-band UVB radiation therapy suppresses the IL-23/IL-17 axis in normalized psoriasis plaques In situ immune response in human chromoblastomycosis--a possible role for regulatory and Th17 T cells

P2860

Q24623195-0F7C41AF-31F5-4E62-B332-331365A2CC45 Q24629315-0ABAC25F-DBB2-4BDD-BAD2-36F38EA5EF05 Q26799069-C63998D7-E74C-485F-99C9-8BED60C9262F Q27001941-5E5375E5-7D17-4BC2-98A7-9578704179CE Q27026785-A34F1A34-E075-4561-9940-C9A1444A0C8A Q28069227-63AE38DE-88D2-4AFC-9225-96D045CD95EF Q28073922-20B41CD5-CD08-4D40-BA42-AD9666E75862 Q28081241-BF219120-902F-438C-A464-24CEAA8601BE Q28268370-71CB5741-F0F7-4D38-B998-DD433593F6BA Q28280687-31F887DF-3197-4A3F-B2E5-9A8BA1D53FD3 Q28732143-7F9137DD-8F67-4F4E-8F6C-92105CFB8F6E Q30412650-376F15F2-0743-498C-A588-6C89822CB926 Q30525640-A9A492E2-9109-4B22-A9AC-814D731EA90A Q33344508-7579C5F4-8437-46D1-9224-DC9F3000F83A Q33485227-5C8C796F-EDE8-42DE-874B-C2A02339A03F Q33564666-66264800-2C75-4483-83B9-A420E73EF250 Q33565663-33AB67AD-C80C-4F98-BE59-468921662497 Q33625887-B4FF57DF-0CC8-4EFC-81F7-C79B0157996D Q33687980-36AC6011-BCF5-4CA6-A32F-C17AC9825A59 Q33757576-9C32C451-756E-4662-B78A-88FAB95F855E Q33760897-2B70B3CD-F969-4CA1-B80F-D022B4B9ABC6 Q33870985-069EDE4B-F005-4754-8DDB-29DC49E669E6 Q33889471-4BA1CC74-AFB8-4881-97FE-A3167F5D09AB Q33915311-D6305B3B-E94B-4611-B7AE-0ED2DFA052D9 Q33941199-4A62E547-9103-451D-8450-41E5B235B783 Q33969217-860BD0B5-45E7-49D1-BFEA-0A68C982068B Q33990291-114D8E42-470F-418E-A5E4-1A252182A840 Q34006908-5C6C4040-D4F9-4699-A54D-EF7D19F2EE79 Q34019278-7ED068CF-65DB-433E-9B21-EB8F9DF838BD Q34021856-00D0A347-4D58-4ADE-9A86-02AC96D54F13 Q34025504-DE608A64-A302-4F64-AD14-DF6B5A53C6E6 Q34030644-EDCCC9F4-7373-4D87-BB33-308BF0DC413F Q34041797-9435F338-E301-4FFE-8F11-CC7E445B398E Q34076431-DAEEAADA-BA49-4D04-B928-5C39B778099C Q34089304-8D114DD6-D624-4BF3-8714-ED9536466CF2 Q34099814-F1C18046-B279-40D0-9413-60BA0DF9BF98 Q34130103-25E97AEE-E83B-436F-BB20-5773A69FA7FA Q34180103-88873E2C-3F23-4F19-AC94-FE664C9EA70B Q34200331-992A8817-EA9E-46F1-BBC9-4871DC128D28 Q34214700-1392DA38-A447-49CF-A98C-2E82359CB36B

P2860

Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses.

http://www.wikidata.org/entity/Q36294340

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Amelioration of epidermal hype ...... d with reduced Th17 responses.

@ast

Amelioration of epidermal hype ...... d with reduced Th17 responses.

@en

type

label

Amelioration of epidermal hype ...... d with reduced Th17 responses.

@ast

Amelioration of epidermal hype ...... d with reduced Th17 responses.

@en

prefLabel

Amelioration of epidermal hype ...... d with reduced Th17 responses.

@ast

Amelioration of epidermal hype ...... d with reduced Th17 responses.

@en

P1433

Q36294340-835BD161-28E6-43F7-B1DD-217DBEFDBA24

P1476

Q36294340-8487DBDD-8014-4F41-9060-EC5F602880B1

P2093

Q36294340-2AB0FEE6-09A1-48AA-80E0-4E69368EADBD

Q36294340-2F740260-7136-4B51-ADEB-ED41E6022121

Q36294340-65EED1AD-CDAC-46CF-9E89-D49D50A6E98A

Q36294340-67A64712-219F-4C04-9B30-EB302FF25DFC

Q36294340-B6F71AEE-721B-499E-8BC9-347718C5642D

Q36294340-C8F2CAC7-BE09-4EEA-9273-8EE52BD2F069

Q36294340-DFE856A8-FA0E-4358-86BE-F0A79C9B1BCE

Q36294340-EA9DD158-45FC-4695-9164-04E50C0A9310

Q36294340-F4DDC813-8BF0-44CD-A342-A735BF5A2E50

Q36294340-F4E69127-198A-4001-9DBB-5EB48CA88C25

P2860

Q36294340-0C059538-9613-4B50-8319-B11CB17BFE75

Q36294340-0D3BCF74-0E6E-41FD-AC12-D8AA9BC05D1E

Q36294340-17792B61-F149-4DD9-9B4A-0F590620B207

Q36294340-1BBE1B8F-867B-46DB-907C-5AE84BE48669

Q36294340-300B8468-AB86-4960-9293-23452C4448EE

Q36294340-382AA2AB-4A59-4023-A3DD-5D307C320B28

Q36294340-411DB1B2-8B74-4D08-9FFF-CC70DFA75CB6

Q36294340-42389414-2A87-4AB8-AAAC-D0AABEC8CC41

Q36294340-42A8438F-6C04-4B09-8766-61EA4DC8F078

Q36294340-4BB1E178-F198-41CF-AE30-656612CA1473

P304

Q36294340-CEE3F72F-D8C9-4885-B8E2-252B028294BE

P31

Q36294340-5F27D1FA-3CFC-400C-97C4-EC414262A481

P356

Q36294340-F8EFE39F-454F-417B-BD2A-3155B37424E4

P407

Q36294340-2DD78A8E-6C2D-4255-BF20-5C7B838C43D6

P433

Q36294340-1D778B12-B440-4E32-9B85-AA43AC18158E

P478

Q36294340-F4A61724-F278-4067-8A31-A0720623A45D

P50

Q36294340-90FCBD22-3D7A-4552-B8CB-8F49635A23C1

P577

Q36294340-95A4C6AF-DC98-4705-B5DB-849D6077E1A4

P5875

Q36294340-7A1B6AF7-44FE-4E77-8DB3-55ACA2926774

P698

Q36294340-A91D3573-BA39-4E61-8302-0DD461040F33

P921

Q36294340-AB646523-CBBD-4DCD-B6EE-E6515211BCE6

P932

Q36294340-E771668B-91C6-4DD6-AB1A-8AB79260D1C2

P356

P1433

Journal of Experimental Medicine

P1476

Amelioration of epidermal hype ...... d with reduced Th17 responses.

@en

P2093

Artemis Khatcherian

http://www.w3.org/2001/XMLSchema#string

Inna Novitskaya

http://www.w3.org/2001/XMLSchema#string

Irma Cardinale

http://www.w3.org/2001/XMLSchema#string

James G Krueger

http://www.w3.org/2001/XMLSchema#string

Judilyn Fuentes-Duculan

http://www.w3.org/2001/XMLSchema#string

Lisa C Zaba

http://www.w3.org/2001/XMLSchema#string

Mark J Bluth

http://www.w3.org/2001/XMLSchema#string

Mary Sullivan-Whalen

http://www.w3.org/2001/XMLSchema#string

Mayte Suárez-Fariñas

http://www.w3.org/2001/XMLSchema#string

Patricia Gilleaudeau

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris

A statistically valid alternative to the TDT

Transforming growth factor-beta induces development of the T(H)17 lineage

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

Phenotypic and functional features of human Th17 cells

Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

Increased expression of interleukin 17 in inflammatory bowel disease

Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris

P304

3183-3194

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20071094

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

204

http://www.w3.org/2001/XMLSchema#string

P50

Michelle A Lowes

P577

2007-11-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5807781

http://www.w3.org/2001/XMLSchema#string

P698

18039949

http://www.w3.org/2001/XMLSchema#string

P921

P932

2150965

http://www.w3.org/2001/XMLSchema#string